The Safety and Tolerability of Engensis (VM202) in Patients With Charcot-Marie-Tooth Disease Subtype 1A (CMT1A)
Condition: CMT Intervention: Biological: Engensis (VM202) Sponsor: Helixmith Co., Ltd. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Charcot-Marie-Tooth Disease | Research